Circulating microRNAs: Biomarkers of disease
Y Wu, Q Li, R Zhang, X Dai, W Chen, D Xing - Clinica Chimica Acta, 2021 - Elsevier
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with
approximately 20–24 nucleotides and are associated with a broad range of biological …
approximately 20–24 nucleotides and are associated with a broad range of biological …
MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
J Matuszyk - Molecular Medicine, 2022 - Springer
Background The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several
types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene …
types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene …
Screening of non-invasive miRNA biomarker candidates for metastasis of gastric cancer by small RNA sequencing of plasma exosomes
Y Zhang, T Han, D Feng, J Li, M Wu, X Peng… - …, 2020 - academic.oup.com
Gastric cancer remains one of the most lethal and prevalent malignancies, particularly in
China. The majority of patients are diagnosed with gastric cancer at the late stages of the …
China. The majority of patients are diagnosed with gastric cancer at the late stages of the …
Function and mechanisms of microRNA‑20a in colorectal cancer
Z Xiao, S Chen, S Feng, Y Li, J Zou… - Experimental and …, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is the third most common malignancy and the second leading
cause of cancer‑associated mortality worldwide. CRC currently has no specific biomarkers …
cause of cancer‑associated mortality worldwide. CRC currently has no specific biomarkers …
LncRNA MEG3 promotes endoplasmic reticulum stress and suppresses proliferation and invasion of colorectal carcinoma cells through the MEG3/miR-103a-3p/PDHB …
W Guoqin, YE Qiuwen, N Shujuan… - …, 2021 - search.ebscohost.com
LncRNA maternally expressed gene 3 (MEG3) is a potential prognostic and diagnostic
biomarker in colorectal carcinoma (CC). However, its cellular functions and mechanism …
biomarker in colorectal carcinoma (CC). However, its cellular functions and mechanism …
Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis
The aim of this study was to determine oncogenic and tumor-suppressing miRNA profiles
associated with the development and progression of cancer using tumor tissues from …
associated with the development and progression of cancer using tumor tissues from …
MicroRNAs associated with colon cancer: new potential prognostic markers and targets for therapy
J Zhu, Y Xu, S Liu, L Qiao, J Sun… - Frontiers in Bioengineering …, 2020 - frontiersin.org
MicroRNAs (miRNAs) are a kind of non-coding RNA (ncRNA) that regulate the expression of
target genes and play a role in the occurrence and development of cancers. Colon cancer …
target genes and play a role in the occurrence and development of cancers. Colon cancer …
miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway
J Xu, X Li, P Zhang, J Luo, E Mou… - Oncology …, 2022 - spandidos-publications.com
Breast cancer (BC) is a commonly identified life‑threatening type of cancer and a major
cause of death among women worldwide. Several microRNAs (miRs), including miR‑143 …
cause of death among women worldwide. Several microRNAs (miRs), including miR‑143 …
Extracellular vesicle lincRNA-p21 expression in tumor-draining pulmonary vein defines prognosis in NSCLC and modulates endothelial cell behavior
JJ Castellano, RM Marrades, L Molins, N Viñolas… - Cancers, 2020 - mdpi.com
Hypoxia-induced upregulation of lincRNA-p21 in tumor tissue was previously shown by our
group to be related to poor prognosis in resected non-small cell lung cancer (NSCLC) …
group to be related to poor prognosis in resected non-small cell lung cancer (NSCLC) …
[HTML][HTML] Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer
H Jacob, L Stanisavljevic, KE Storli, KE Hestetun… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …